Sisram Medical seeks share buyback, re-election of directors

Sisram Medical is proposing the re-election of directors and seeking general mandates to buy back shares and issue new shares. The company plans to request authorization to repurchase up to 10% of its issued shares (excluding treasury shares), which amounts to 46,834,309 shares based on the current issued share capital. Additionally, Sisram is seeking a general mandate to issue new shares not exceeding 20% of the issued share capital (excluding treasury shares), totaling 93,668,618 shares. The annual general meeting is scheduled for June 24, 2025, in Hong Kong, where shareholders will vote on these proposals. Re-election of executive directors, Yi LIU and Jiahong LI, and non-executive directors, Rongli FENG and Jenny CHEN are to be voted on at the meeting.